Takara Bio Inc.
4974.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥9,528,000 | ¥9,266,000 | ¥15,757,000 | ¥9,524,000 |
| % Growth | 2.8% | -41.2% | 65.4% | – |
| Cost of Goods Sold | ¥3,968,000 | ¥4,262,000 | ¥6,060,000 | ¥5,599,000 |
| Gross Profit | ¥5,560,000 | ¥5,004,000 | ¥9,697,000 | ¥3,925,000 |
| % Margin | 58.4% | 54% | 61.5% | 41.2% |
| R&D Expenses | ¥1,710,000 | ¥1,787,000 | ¥1,779,000 | ¥1,637,000 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥4,262,000 | ¥4,820,000 | ¥4,182,000 | ¥4,192,000 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥135,000 | ¥193,000 | ¥0 | -¥14,000 |
| Operating Expenses | ¥6,107,000 | ¥6,800,000 | ¥5,961,000 | ¥5,815,000 |
| Operating Income | -¥547,000 | -¥1,796,000 | ¥3,736,000 | -¥1,890,000 |
| % Margin | -5.7% | -19.4% | 23.7% | -19.8% |
| Other Income/Exp. Net | -¥3,994,000 | ¥14,000 | -¥355,000 | ¥79,000 |
| Pre-Tax Income | -¥4,541,000 | -¥1,782,000 | ¥3,381,000 | -¥1,811,000 |
| Tax Expense | ¥855,000 | -¥289,000 | ¥947,000 | ¥67,000 |
| Net Income | -¥5,401,000 | -¥1,510,000 | ¥2,420,000 | -¥1,891,000 |
| % Margin | -56.7% | -16.3% | 15.4% | -19.9% |
| EPS | -44.84 | -12.55 | 20.09 | -15.7 |
| % Growth | -257.3% | -162.5% | 228% | – |
| EPS Diluted | -44.84 | -12.55 | 20.09 | -15.7 |
| Weighted Avg Shares Out | 120,415 | 120,415 | 120,415 | 120,416 |
| Weighted Avg Shares Out Dil | 120,415 | 120,415 | 120,415 | 120,416 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥42,000 | ¥50,000 | ¥80,000 | ¥71,000 |
| Interest Expense | ¥126,000 | ¥117,000 | ¥5,000 | ¥5,000 |
| Depreciation & Amortization | ¥1,336,000 | ¥1,360,000 | ¥1,104,000 | ¥1,345,000 |
| EBITDA | -¥3,078,000 | -¥305,000 | ¥4,492,000 | -¥570,000 |
| % Margin | -32.3% | -3.3% | 28.5% | -6% |